This investigation reveals adaptive synaptic change in Alzheimer's, suggesting implications for therapeutic strategies.
Synapse loss is the strongest structural correlate of cognitive decline in Alzheimer's disease (AD), yet the prevailing narrative treats it as a purely degenerative process. Here we propose that a substantial fraction of early synaptic change in AD represents an adaptive, energy-conserving response by the metabolically prioritising brain — one that becomes self-defeating as the underlying energy crisis deepens. We integrate three recent lines of evidence: (i) Peters' Selfish Brain theory, which posits that the brain prioritises its own glucose supply at the expense of peripheral organs; (ii) the discovery that approximately 25% of synapses in adult mouse neocortex are functionally silent, residing on NMDA-receptor-only filopodia that lack AMPA receptors (Vardalaki et al., Nature, 2022); and (iii) the finding that memantine, the standard NMDA-receptor antagonist used in AD, also partially inhibits calcium-permeable AMPA receptors (Carrillo et al., Nature Communications, 2025). We propose a four-stage model: (1) preclinical amyloid accumulation triggers cerebral glucose hypometabolism, prompting adaptive synaptic silencing through AMPA-receptor internalisation and morphological regression from mature spines to filopodia; (2) the silent synapse reservoir expands while the glucose-dependent molecular machinery for reactivation — CaMKII signalling, AMPA-receptor trafficking, Arp2/3-mediated actin remodelling — becomes progressively unavailable; (3) brain-pull incompetence triggers systemic metabolic compensation, creating a feed-forward loop; (4) the structural scaffold itself degrades through complement-mediated pruning of inactive synapses, rendering connectivity collapse irreversible. The framework generates several testable predictions, including a non-monotonic filopodial density curve across AD stages, and identifies the Stage 2–3 transition as a critical therapeutic window. We discuss pharmacological implications, arguing that memantine may inadvertently narrow the plasticity window, and propose that combination strategies pairing NMDA-receptor modulation with AMPA-receptor positive allosteric modulators could restore the conditions under which the silent synapse reservoir can be recruited.
No takes yet. Share an insight, caveat, or question.
Topcular et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: